Abstract

Antibiotic use after a typhoid conjugate vaccine: factors beyond vaccination in low-income countries

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data
Latif Ndeketa ... Neil French
The Lancet Global Health | VOL. 11
Latif Ndeketa, et. al.Latif Ndeketa ... Neil French
25 Nov 2022
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial
Maurice Mbewe ... Pratiksha Patel
The Lancet Global Health | VOL. 10
Maurice Mbewe, et. al.Maurice Mbewe ... Pratiksha Patel
09 Aug 2022
The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK.
... Firdausi Qadri
Vaccine | VOL. 35
, et. al. ... Firdausi Qadri
10 Aug 2017
Comparison of anti-Vi IgG responses between two clinical studies of typhoid Vi conjugate vaccines (Vi-DT vs Vi-TT).
Deok Ryun Kim ... Sushant Sahastrabuddhe
PLoS neglected tropical diseases | VOL. 14
Deok Ryun Kim, et. al.Deok Ryun Kim ... Sushant Sahastrabuddhe
23 Mar 2020
View more papers

More From: The Lancet Global Health

Paper Title
Journal
Date
Author
New insights into cancer epidemiology and survival in sub-Saharan Africa
Jennifer Ann Geel ... Yusuf Mayet
The Lancet Global Health | VOL. 12
Jennifer Ann Geel, et. al.Jennifer Ann Geel ... Yusuf Mayet
01 Jun 2024
Handheld echocardiography for the screening and diagnosis of rheumatic heart disease: a systematic review to inform WHO guidelines
Rui Providência ... Farhad Shokraneh
The Lancet Global Health | VOL. 12
Rui Providência, et. al.Rui Providência ... Farhad Shokraneh
01 Jun 2024
TREAT-B or Treat All: time for a broader vision on hepatitis B elimination
Ankur Jindal ... Shiv K Sarin
The Lancet Global Health | VOL. 12
Ankur Jindal, et. al.Ankur Jindal ... Shiv K Sarin
01 Jun 2024
TREAT-B or Treat All: time for a broader vision on hepatitis B elimination – Author's reply
Liem Binh Luong Nguyen ... Yusuke Shimakawa
The Lancet Global Health | VOL. 12
Liem Binh Luong Nguyen, et. al.Liem Binh Luong Nguyen ... Yusuke Shimakawa
01 Jun 2024
View more papers